First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors
Clinical trial NCT04505839 · COMPLETED
Trial details
- NCT number
- NCT04505839
- Sponsor
- ST Pharm Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2023-03-07
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.